中药复方预防结直肠癌的疗效、机制与优势
本文综述近三年文献,聚焦中药复方(TCMFs)防治肠道癌前病变的疗效与机制。葛根芩连汤、芍药汤、乌威丸等可降低疾病活动指数、抑制肠道炎症、维持体重与肠道功能;机制涉及保护上皮屏障、调节菌群与代谢、调控巨噬细胞极化及维持免疫平衡。
要点
- 葛根芩连汤等复方对肠道癌前病变有治疗作用,助于预防结直肠癌。
- 经典药对与植物来源纳米颗粒在癌前病变治疗中显示更优疗效。
- 机制包括保护肠屏障、调菌群代谢、调巨噬细胞极化与免疫平衡。
核心结论
- 中药复方在预防结直肠癌方面具有较大潜力和明确机制,为临床应用提供科学依据。
研究设计与样本
- 综述检索PubMed与中国知网近三年文献,关键词包括中药复方、药对、植物来源纳米颗粒等,筛选肠道癌前病变相关文章。
主要发现
- 葛根芩连汤、芍药汤、乌威丸等对肠道癌前病变有显著治疗作用。
- 疗效表现为疾病活动指数评分降低、肠道炎症抑制、体重与肠道功能维持。
- 经典中药药对与草本植物细胞外囊泡样纳米颗粒在治疗癌前病变中疗效更优。
- 机制涉及保护上皮屏障、调节肠道菌群及相关代谢、调控巨噬细胞极化、维持免疫平衡。
临床怎么用
- 可关注葛根芩连汤等复方在肠道癌前病变中的潜在应用,结合机制开展临床与基础研究。
局限性
- 中药复方预防结直肠癌的潜在机制尚未完全阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: The Traditional Chinese Medicine Formulas (TCMFs) represent a distinctive medical approach to disease treatment and have been utilized in clinical practice for treating intestinal diseases for thousands of years. Recently, TCMFs have received increasing attention due to their advantages of high efficiency, safety, as well as low toxicity, providing promising strategies for preventing colorectal carcinoma (CRC). Nonetheless, the potential mechanism of TCMFs in preventing CRC has not been fully elucidated. AIM OF THE STUDY: The literature from the past three years was reviewed to highlight the therapeutic effects and underlying mechanisms of TCMFs in preventing CRC. MATERIALS AND METHODS: The keywords have been searched, including "traditional Chinese medicine formulas," "herb pairs," "Herbal plant-derived nanoparticles," et al. in "PubMed" and "China National Knowledge Infrastructure (CNKI)," and screened published articles related to the treatment of intestinal precancerous lesions. This review primarily examined the effectiveness and mechanisms of TCMFs in treating intestinal precancerous lesions, highlighting their significant potential in preventing CRC. RESULTS: Gegen Qinlian decoction, Shaoyao decoction, Wu Wei Wan, etc., exert substantial therapeutic effects on intestinal precancerous lesions. These therapeutic effects are demonstrated by a reduction in disease activity index scores, suppression of intestinal inflammation, and preservation of body weight and intestinal function, all of which contribute to the effective prevention of CRC. Besides, the classic Chinese herbal pairs and the extracellular vesicle-like nanoparticles of herbaceous plants have demonstrated superior efficacy in the treatment of intestinal precancerous lesions. Mechanistically, protecting the epithelial barrier, regulating gut microbiota as well as related metabolism, modulating macrophage polarization, and maintaining immune balance contribute to the role of TCMFs in CRC prevention. CONCLUSIONS: This review demonstrates the great potential and mechanism of TCMFs in CRC prevention and provides a scientific basis for their utilization in CRC prevention.
引用
- Tang X, He M, Ren Y, et al. Traditional Chinese Medicine formulas-based interventions on colorectal carcinoma prevention: The efficacies, mechanisms and advantages. J Ethnopharmacol. 2024. PMID: 39471879. doi:10.1016/j.jep.2024.119008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。